XML 18 R8.htm IDEA: XBRL DOCUMENT v3.25.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net (loss) income $ (92,698) $ 134,053
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Loss (gain) on sale or write down of assets, net 24,472 (288,911)
Depreciation and amortization 186,418 145,789
Amortization of discount on mortgage notes payable 18,241 2,067
Amortization of share and unit-based plans 8,505 5,189
Straight-line rent and amortization of above and below market leases (2,378) 2,392
Provision for doubtful accounts 2,356 4,432
Income tax benefit (1,010) (966)
Equity in loss of unconsolidated joint ventures 1,274 130,113
Change in fair value of financing arrangement obligation 0 (13,795)
Changes in assets and liabilities, net of dispositions:    
Tenant and other receivables 21,677 27,340
Other assets 10,799 (5,432)
Due from affiliates (1,641) 1,457
Accounts payable and accrued expenses 14,439 5,703
Other accrued liabilities (31,444) (20,905)
Net cash provided by operating activities 159,010 128,526
Cash flows from investing activities:    
Acquisitions of property (266,926) (41,852)
Development, redevelopment, expansion and renovation of properties (59,956) (50,312)
Property improvements (17,544) (23,132)
Deferred leasing costs (2,191) (2,979)
Distributions from unconsolidated joint ventures 51,839 57,698
Contributions to unconsolidated joint ventures (110,323) (30,013)
Cash acquired from acquisition of unconsolidated joint ventures 0 7,373
Derecognition of cash previously held by a consolidated joint venture to an unconsolidated joint venture 0 (13,005)
Proceeds from sale of assets 90,441 12,872
Net cash used in investing activities (314,660) (83,350)
Cash flows from financing activities:    
Proceeds from mortgages, bank and other notes payable 440,000 289,996
Payments on mortgages, bank and other notes payable (134,666) (257,922)
Deferred financing costs (1,729) (5,371)
Payments on finance leases (4,408) (1,242)
Costs from stock offerings (639) (66)
Employee stock purchases 1,251 1,021
Dividends and distributions (96,165) (80,232)
Net cash provided by (used in) financing activities 203,644 (53,816)
Net increase (decrease) in cash, cash equivalents and restricted cash 47,994 (8,640)
Cash, cash equivalents and restricted cash, beginning of period 177,479 190,294
Cash, cash equivalents and restricted cash, end of period 225,473 181,654
Supplemental cash flow information:    
Cash payments for interest, net of amounts capitalized 101,276 91,503
Non-cash investing and financing transactions:    
Accrued development costs included in accounts payable and accrued expenses and other accrued liabilities 43,059 39,686
Derecognition of previously consolidated property and related liabilities to investment in unconsolidated joint venture 0 347,290
Conversion of Operating Partnership Units to common stock 118 5,970
Assets acquired from unconsolidated joint venture 0 621,701
Liabilities assumed from unconsolidated joint venture $ 0 $ 558,439